Skip to main content
Log in

Effects of sodium cyanate in mice bearing B16 melanoma

  • Original Articles
  • Cyanate, B16 Melanoma
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Sodium cyanate injected IP at a dose level of 200 or 250 mg/kg caused a 90% or greater inhibition of the incorporation of [3H]thymidine into DNA of B16 melanoma transplanted SC in mice. Despite the inhibitory effect of sodium cyanate on precursor incorporation into DNA, no significant effect on host survival was observed when sodium cyanate was administered as a single agent in the diet, in drinking water, or by IP injection to mice that had received IP transplants of B16 melanoma. The action of melphalan and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in prolonging the survival time of melanoma-bearing mice was not enhanced by combined treatment with sodium cyanate. However, combined injections of sodium cyanate and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) increased the survival of tumor-bearing mice significantly more than injections of BCNU alone at a lower dose than the maximum tolerated one. These data and other studies suggest that B16 melanoma may be less responsive to the action of sodium cyanate than are murine leukemic cells or rat hepatomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Allfrey VG, Boffa LC, Vidali G (1977) Selective inhibition with sodium cyanate of protein synthesis in colon cancer cells. Cancer 40:2692–2698

    Google Scholar 

  2. Birch KM, Schütz F (1946) Actions of cyanate. Br J Pharmacol 1:186–193

    Google Scholar 

  3. Boffa LC, Kozak S, Allfrey VG (1981) Activation of sodium cyanate for selective inhibition of protein synthesis in cultured tumor cells. Cancer Res 41:60–66

    Google Scholar 

  4. Burton KA (1956) Study of the conditions and mechanism of the disphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:316–323

    Google Scholar 

  5. Dufour M, St. Germain J, Skalski V, Dorato A, Lazarus P, Panasci LC (1984) Effect of administration of sodium cyanate and melphalan on the lifespan of P388 tumor-bearing CD2Fl mice. Cancer Chemother Pharmacol 12:94–97

    Google Scholar 

  6. Dustin P (1947) Some new aspects of mitotic poisoning. Nature 159:794–797

    Google Scholar 

  7. Herrera-Ornelas L, Petrelli NJ, Madajewicz S, Mittelman A, Allfrey VG (1985) Phase-1 clinical trial of sodium cyanate in patients with advanced colorectal carcinoma. Oncology 42:236–241

    Google Scholar 

  8. Knox P (1976) Carcinogenic nitrosamides and cell cultures. Nature 259:671–673

    Google Scholar 

  9. Labbe RF (1973) Sodium cyanate: chemical properties relevant to sickle cell disease therapy. J Pharm Sci 62:1727–1729

    Google Scholar 

  10. Lea MA, Koch MR (1979) Effects of cyanate, thiocyanate, and amygdalin on metabolite uptake in normal and neoplastic tissues of the rat. J Natl Cancer Inst 63:1279–1283

    Google Scholar 

  11. Lea MA, Parsons J (1981) Effects of cyanate on the distribution of isotope-labeled H2O and extracellular markers in rat liver and tumors. Cancer Res 41:4988–4992

    Google Scholar 

  12. Lea MA, Koch MR, Allfrey VG, Morris HP (1975a) Inhibition by cyanate of DNA synthesis in hepatomas. Cancer Biochem Biophys 1:129–133

    Google Scholar 

  13. Lea MA, Koch MR, Morris HP (1975b) Tumor-selective inhibition of the incorporation of [3H]-labelled amino acids into protein by cyanate. Cancer Res 35:2321–2326

    Google Scholar 

  14. Lea MA, Luke A, Velazquez O, Carpenter L, Martinson CF, Hill HZ, Hill GJ (1985) Action of cyanate on B16 melanoma. Proc Am Assoc Cancer Res 26:321

    Google Scholar 

  15. Moore JV (1985) Dose-response curves after in vivo experimental chemotherapy: Influence of route of administration on biological outcomes. Cancer Chemother Pharmacol 15:91–92

    Google Scholar 

  16. Sariban E, Erickson LC, Kohn KW (1984) Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas. Cancer Res 44:1352–1357

    Google Scholar 

  17. Wattenberg LW (1981) Inhibition of carcinogen-induced neoplasia by sodium cyanate, tert-butyl isocyanate, and benzyl isothiocyanate administered subsequent to carcinogen exposure. Cancer Res 41:2991–2994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The work described in this paper was supported by NIH grant CA-35315 and a research award from the Veterans Administration

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lea, M.A., Luke, A., Velazquez, O. et al. Effects of sodium cyanate in mice bearing B16 melanoma. Cancer Chemother. Pharmacol. 17, 231–235 (1986). https://doi.org/10.1007/BF00256690

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00256690

Keywords

Navigation